Biohaven Ltd. (BHVN)
Data as of , from SEC Form 4 filings.
See up to 3 months of BHVN. The 7-day demo opens the 1M and 3M ranges and puts BHVN on your watchlist.
Start 7-day demoLatest BHVN insider trades
About Biohaven Ltd. (BHVN)
Biohaven Ltd. is an SEC registrant, filing under CIK 0001935979, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
BHVN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 1,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BHVN insider transactions (Form 4)
2725 Form 4 filings on record, the earliest from Oct 3, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Kimberly Gentile - Officer | Grant or award | Stock Options (Right to buy) | 1,000 | $0.00 | - | |
| Kishan Mehta - Director | Grant or award | Stock Options (Right to buy) | 68,693 | $0.00 | - | |
| Gregory Bailey - Director | Grant or award | Stock Options (Right to buy) | 68,693 | $0.00 | - | |
 Michael Thomas Heffernan - Director | Grant or award | Stock Options (Right to buy) | 68,693 | $0.00 | - | |
| Irina Antonijevic - Director | Grant or award | Stock Options (Right to buy) | 68,693 | $0.00 | - | |
| John W. Childs - Director | Grant or award | Stock Options (Right to buy) | 68,693 | $0.00 | - | |
| Robert J. Hugin - Director | Grant or award | Stock Options (Right to buy) | 68,693 | $0.00 | - | |
| Julia P. Gregory - Director | Grant or award | Stock Options (Right to buy) | 68,693 | $0.00 | - | |
| Kishan Mehta - Director | Gift | Common Shares | 17,342 | $0.00 | - | |
| Kishan Mehta - Director | Gift | Common Shares | 17,342 | $0.00 | - | |
| John W. Childs - Director | Open-market purchase | Common Shares | 28,400 | $30.43 | $864K | |
 Matthew Buten - Officer | Grant or award | Stock Options (Right to buy) | 175,000 | $0.00 | - | |
| Kimberly Gentile - Officer | Grant or award | Stock Options (Right to buy) | 175,000 | $0.00 | - | |
| George C. Clark - Officer | Grant or award | Stock Options (Right to buy) | 50,000 | $0.00 | - | |
| Bruce Car - Officer | Grant or award | Stock Options (Right to buy) | 175,000 | $0.00 | - | |
| Vlad Coric - Officer | Grant or award | Stock Options (Right to buy) | 550,000 | $0.00 | - | |
| George C. Clark - Officer | Open-market purchase | Common Shares | 17,000 | $8.52 footnote F1 | $145K | |
| ||||||
| Vlad Coric - Officer | Open-market purchase | Common Shares | 333,333 footnote F1 | $7.50 | $2.50M | |
| Vlad Coric - Officer | Open-market purchase | Common Shares | 333,333 footnote F1 | $7.50 | $2.50M | |
| ||||||
| Gregory Bailey - Director | Open-market purchase | Common Shares | 400,000 footnote F1 | $7.50 | $3.00M | |
| ||||||
| John W. Childs - Director | Open-market purchase | Common Shares | 3,333,333 footnote F1 | $7.50 | $25.00M | |
| ||||||
| Robert J. Hugin - Director | Grant or award | Stock Options (Right to buy) | 31,716 | $0.00 | - | |
| Julia P. Gregory - Director | Grant or award | Stock Options (Right to buy) | 31,716 | $0.00 | - | |
| John W. Childs - Director | Grant or award | Stock Options (Right to buy) | 31,716 | $0.00 | - | |
| John W. Childs - Director | Open-market purchase | Common Shares | 29,000 | $35.94 | $1.04M | |
| John W. Childs - Director | Open-market purchase | Common Shares | 21,052 | $47.50 | $1.00M | |
| Vlad Coric - Officer | Open-market purchase | Common Shares | 21,052 | $47.50 | $1.00M | |
BHVN insider trading FAQ
What is the latest insider trade for BHVN?
Biohaven Ltd. (BHVN) had 1 insider filing in the last 90 days, with the most recent on 2026-09-17. The full record for BHVN runs to 25 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BHVN stock?
No insider purchases of BHVN were filed in the last 90 days. 9 purchases are on record for this company.
How many insiders are selling BHVN stock?
No insider sales of BHVN were filed in the last 90 days.
Where can I see BHVN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BHVN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kimberly Gentile view on EDGAR
- - Kishan Mehta view on EDGAR
- - Gregory Bailey view on EDGAR
- - Michael Thomas Heffernan view on EDGAR
- - Irina Antonijevic view on EDGAR
- - John W. Childs view on EDGAR
- - Robert J. Hugin view on EDGAR
- - Julia P. Gregory view on EDGAR
- - Kishan Mehta view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where BHVN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BHVN with a 7-day demo
- BHVN on your watchlist
- Every BHVN Form 4 filing on record
- Up to 3 months of BHVN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
